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Journal of Investigative Dermatology (JID) Editor-in-Chief Barbara Gilchrest and I have found ourselves in an unexpected 
situation this year—she as a former President 
of the Society for Investigative Dermatology 
(SID), currently serving as JID Editor, and I 
as former Editor of JID, currently serving as 
president of the SID. This situation has allowed 
us to continue our long-term collaboration, 
from Boston and Dallas, respectively, as sup-
porters of the cutaneous biology enterprise. 
Dr. Gilchrest has continued the tradition of 
featuring a unique theme for each volume of 
JID, identifying 2013 as the “Year of Unity.” 
Editorials and journal covers over the past year 
have emphasized and reminded readers of 
that necessity. As President of the SID for most 
of the same year (May 2013 to May 2014), I 
chose at first to follow suit by emphasizing 
simple unity as part of the agenda for my year. 
It should be remembered that SID presidents 
serve for one year, meaning that holders of 
that responsibility should be careful to con-
struct goals that can be accomplished within 
a reasonable amount of time or goals that will 
remain alive in succeeding years. My one-
year term contrasts with terms of JID editors, 
who have five years to leave lasting records 
of achievement. This gave rise to my decision 
to collaborate on something important rather 
than to distract with something new.
However, in putting thoughts together for 
this Editorial, it became apparent that I was 
about to take Dr. Gilchrest’s emphasis in a 
somewhat different direction by including spe-
cific action steps beyond that of unity itself. 
After several exchanges about my very rough 
draft, she decided to continue the unity empha-
sis in 2014, but with an extension to “Unity in 
Action.” Her January editorial will explain her 
reasoning, and I now explain mine.
To begin the transition, I return to Dr. 
Gilchrest’s inaugural Editorial, in which she 
described “Goals of Unity” for 2013. It is these 
goals that I have chosen to support by asking 
members of the SID to join her with participa-
tory steps (Gilchrest, 2013):
Overall, the vision is of a single unified 
community, with the specific goals of each sub-
group supported by the whole, to the benefit of 
all. I see these goals as interrelated: (i) enhancing 
our ability to prevent and treat skin disease 
through new knowledge; (ii) strengthening the 
investigative community responsible for these 
advances; (iii) communicating the relevance of 
research discoveries to the larger medical and 
scientific communities; and (iv) achieving opti-
mal interactions among investigators, trainees, 
and other stakeholders worldwide.
As President of the SID, it is my responsibility 
to help guide the Society and at the same time to 
encourage its members to participate in (that is, 
to effect) its agenda. However, rather than dis-
cuss each element in Dr. Gilchrest’s agenda in 
sequence, I will cut across the four goals with 
recommendations that may address more than 
one at a time. This takes the form of suggestions 
of action for members of SID toward Unity in 
Action. Those who know me recognize that I 
prefer action to study and contemplation.
Join the political enterprise. We should not 
only communicate the relevance of our inves-
tigative successes to the greater scientific com-
munity but also communicate successes to our 
congressional representatives and, important-
ly, to the congressional aides in their offices. 
I encourage all of us to write to our congres-
sional representatives, in both the House and 
the Senate, and then to take the next step by 
visiting them and their aides in local offices. 
Personal visits are much more effective than 
e-mail messages (which are nearly useless) and 
letters. Those who visit local offices might want 
to offer to serve in the future as “experts” when 
scientific questions arise. Keep in mind that 
congressional aides are commonly fresh out 
of college, and they do not stay long in those 
offices, meaning that there is a constant need 
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for new information and new scientific insight. When one 
goes back for a second visit, it is not uncommon for the 
aide representing science and technology to have gone 
on to a different responsibility or different employment. 
In supporting the need for sustained research funding, it is 
best to offer support for general initiatives of the National 
Institutes of Health (NIH) and the National Science 
Foundation (NSF) rather than one’s own agenda or the 
agenda of one’s institution. As citizens of our congressio-
nal districts and states, we are certainly free to do this. 
But there is an additional warning: do not go alone. When 
one visits an office alone, a common interpretation will 
be that one is advocating for one’s own academic (or even 
financial) success. This is not good. To avoid this misun-
derstanding, take a patient with you. Invite the patient to 
enter the room first, let the patient discuss his issues and 
how he envisions that research may lead to novel thera-
pies; let him discuss access to medical care and insur-
ance issues. You, the scientist and/or clinical investigator, 
should serve as a source of information rather than as an 
advocate. Once questions are asked, you, the academic 
scientist, become the center of attention.
I have found that legislators and aides respond almost 
exclusively to patients who live in their districts rather 
than to investigators. Please note in the recommendation 
below my sustained interest in working with patient advo-
cates. It is often useful for a representative of a local or 
national advocacy organization to take part as well. Even 
(and perhaps, especially) members of the SID who are 
not funded by the NIH or NSF should visit congressional 
offices, putting aside any possibility of conflict of interest. 
Toward the end of a visit, while speaking with an aide, I 
have even had the senator or representative come out to 
the meeting room to visit. You are a voter; the patient is a 
voter; the patient advocate is a voter; you will be heard.
advocacy. Three years ago, when I was Editor of JID, 
we devoted one year (2010; volume 130) to patients and 
patient advocacy under the banner of “The Year of the 
Patient.” We attempted to describe to the scientific world 
at large the burden that patients with skin disease bear. 
But the key element that year was the impact of patient 
advocacy organizations on the research enterprise. These 
organizations, such as the Cutaneous Eczema Foundation 
and the National Alopecia Areata Foundation, are high-
ly organized and they support patient advocacy, cre-
ative research, and sources of information for patients. 
Moreover, 16 of the advocacy organizations have com-
bined their efforts and resources in the collective orga-
nization now known as the Coalition of Skin Diseases. 
Member organizations of the Coalition pool their efforts 
while at the same time providing resources to meet their 
own interests.
As noted above, it is helpful for representatives of these 
organizations to visit legislative offices with you, either at 
home or on Capitol Hill in Washington. With much great-
er intensity than scientists can muster, they are able to 
describe patients’ experiences, and they advocate much 
more effectively for the goals of the NIH and NSF.
But my action step goes beyond all of this. My strong 
recommendation is that members of our scientific commu-
nity seek out national and local advocacy organizations 
and join them, with offers to serve in scientific capaci-
ties, including service on advisory boards. Indeed, many 
of our members have done this, but there is always need 
for additional help. Seek out your organization today. Join 
an advocacy organization related to the diseases that you 
study. Make yourself available as a consultant and/or a 
member of the advisory board.
enhance your knowledge of science, culture, econom-
ics, and politics. Science is not conducted in a vacuum; 
rather, it occurs in society, among citizens. In addition to 
knowledge about art, music, history, and economics, one 
is able to navigate the academic enterprise more effective-
ly with the perspective and wit that allows one to over-
come the difficulties and disappointments that invariably 
accompany an academic scientific career. Closer to home, 
however, I have found that my ability to generate enthu-
siasm for new ideas and new directions occurs as I read 
cultural and scientific literature that is not related direct-
ly to my research. Thus, in addition to the journals that 
address issues relevant to their own careers, I encourage 
scientists, especially young scientists, to read more widely 
in the general medical and general scientific literature. 
Such reading commonly offers useful insight into disease 
pathogenesis and knowledge about new techniques and, 
most importantly, analogies to one’s own work. My rec-
ommendation is that each of us should read at least the 
front half of Science, Nature, and JAMA each week. They 
are full of new ideas, and this exercise will offer consider-
able insight, not only into disease but also into the poli-
tics of medical investigation. Consider reading, as much 
as possible, The New York Times (especially Tuesday) or 
the Washington Post each day, The Economist weekly, 
Scientific American monthly, and a local city newspaper. 
No, you do not need to read every page of these publica-
tions; you select and you choose.
Finally, it is useful to develop and practice two- and 
four-minute speeches about your work. Then try them out 
on your neighbors and associates in your nonprofessional 
lives, for example, the lawyer or the engineer down the 
street. What do you do? Why do you do it? What is the 
rationale? So, how is this helpful? You never know when 
an audience may develop—with a potential donor at the 
end of a long clinic, in a congressional office, on the golf 
course with the friend of a colleague, or in the supermar-
ket. Your enthusiasm for your work must tell them that you 
are excited about what you do; it is important to society at 
large, and you are going to tell them something about it. 
Stay in the teaching mode: friends, family members, col-
leagues on study sections, other physicians, and patients.
Give back. There are many ways to give back, including 
mentoring, but at this point I have only one recommenda-
tion: accept with some enthusiasm at least some of your 
invitations to review manuscripts for journals that publish 
articles in your area(s) of interest. This is payback. And 
then share that responsibility and experience with junior 
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colleagues. This is called mentoring. Let the trainee or 
junior colleague write the first draft of a review, and then 
use your corrections as a teaching exercise. Writing is the 
most important communication activity that we engage 
in. Not only is it a fundamental means of communication, 
but it is through examining your own written words that 
you can be certain that you understand a subject. “Write it 
down and you will learn whether you know what you are 
talking about.”
effecting the agenda. Rather than repeating the obvious, let 
me request that all readers now take these recommendations 
and see how they address our Editor’s Goals of Unity. I 
suggest that members of the SID should: (i) join the politi-
cal enterprise, (ii) join and support advocacy organizations, 
(iii) enhance their knowledge of science, culture, economics, 
and politics, and (iv) give back through mentoring.
Paul R. Bergstresser
Editor Emeritus and President, Society for Investigative Dermatology
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